Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Vaxcyte Inc.

    NASDAQ: PCVX · Real-Time Price · USD
    34.23
    -0.33 (-0.95%)
    At close: Jun 16, 2025, 3:59 PM
    34.33
    0.29%
    After-hours: Jun 16, 2025, 04:20 PM EDT

    Vaxcyte Statistics

    Share Statistics

    Vaxcyte has 129M shares outstanding. The number of shares has increased by 18.35% in one year.

    Shares Outstanding

    n/a
    		 129M

    Shares Change (YoY)

    n/a
    		 18.35%

    Shares Change (QoQ)

    n/a
    		 3.31%

    Owned by Institutions (%)

    n/a
    		 99.99%

    Shares Floating

    n/a
    		 125.07M

    Failed to Deliver (FTD) Shares

    n/a
    		 10

    FTD / Avg. Volume

    n/a
    		 n/a

    Short Selling Information

    The latest short interest is 13.2M, so 10.23% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 13.2M

    Short % of Shares Out

    n/a
    		 10.23%

    Short % of Float

    n/a
    		 11.47%

    Short Ratio (days to cover)

    n/a
    		 5.47

    Valuation Ratios

    The PE ratio is -21.53 and the forward PE ratio is -7.67. Vaxcyte's PEG ratio is 2.62.

    PE Ratio

    n/a
    		 -21.53

    Forward PE

    n/a
    		 -7.67

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 2.4

    PB Ratio

    n/a
    		 3.02

    P/FCF Ratio

    n/a
    		 -21.02

    PEG Ratio

    n/a
    		 2.62
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Vaxcyte.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 12.75, with a Debt / Equity ratio of 0.02.

    Current Ratio

    n/a
    		 12.75

    Quick Ratio

    n/a
    		 12.75

    Debt / Equity

    n/a
    		 0.02

    Debt / EBITDA

    n/a
    		 -0.16

    Debt / FCF

    n/a
    		 -0.15

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-1,120,596.62

    Employee Count

    n/a
    		 414

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -52.6% in the last 52 weeks. The beta is 1.2, so Vaxcyte's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.2

    52-Week Price Change

    n/a
    		 -52.6%

    50-Day Moving Average

    n/a
    		 32.68

    200-Day Moving Average

    n/a
    		 77.24

    Relative Strength Index (RSI)

    n/a
    		 49.2

    Average Volume (20 Days)

    n/a
    		 2,504,403

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -569.55M

    Net Income

    n/a
    		 -463.93M

    EBITDA

    n/a
    		 -448.08M

    EBIT

    n/a
    		 -463.93M

    Earnings Per Share (EPS)

    n/a
    		 -3.8
    Full Income Statement

    Balance Sheet

    The company has 387.88M in cash and 71.11M in debt, giving a net cash position of 316.77M.

    Cash & Cash Equivalents

    n/a
    		 387.88M

    Total Debt

    n/a
    		 71.11M

    Net Cash

    n/a
    		 316.77M

    Retained Earnings

    n/a
    		 -1.39B

    Total Assets

    n/a
    		 3.38B

    Working Capital

    n/a
    		 1.62B
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -452.63M and capital expenditures -22.43M, giving a free cash flow of -475.05M.

    Operating Cash Flow

    n/a
    		 -452.63M

    Capital Expenditures

    n/a
    		 -22.43M

    Free Cash Flow

    n/a
    		 -475.05M

    FCF Per Share

    n/a
    		 -3.89
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    PCVX does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for PCVX is $145, which is 319.4% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $145

    Price Target Difference

    n/a
    		 319.4%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 9
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 13.68

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist